Full-Time

Lindus Health

Lindus Health

51-200 employees

Accelerates clinical trials for life sciences

No salary listed

Mid, Senior

United States

Candidates must be based in the PST or MST time zones and will be required to travel for site visits across the US.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Requirements
  • 3+ years of work experience in a clinical trial monitoring role
  • Understanding of risk-proportionate approach to monitoring
  • Strong awareness of clinical trial regulations
  • Great attention to detail
  • Confident communicator with internal and external stakeholders
  • Proactive, organised and creative
  • Comfortable travelling to conduct site visits across the US
  • Based on the PST or MST time zones
Responsibilities
  • Act as primary contact between Lindus Health and recruiting sites to lead effective monitoring according to trial protocols
  • Coordinate and lead monitoring activities and deliverables on a company level
  • Work closely with tech and product teams to help design best-in-class trial monitoring technology
Desired Qualifications
  • Experience in a startup or early-stage environment
  • Previous involvement in UK/EU trials
  • Previous involvement in central monitoring

Lindus Health focuses on speeding up clinical trials to help patients access new treatments more quickly. The company operates differently from traditional contract research organizations (CROs) by using a fixed-price model for studies and milestone-based payments, which aligns their incentives with those of their clients. Lindus Health combines a skilled clinical operations team with a specialized software platform and access to a vast database of 30 million Electronic Health Records. They handle all aspects of clinical studies, including designing the study, recruiting patients, capturing clinical data, monitoring progress, and managing projects. By doing so, Lindus Health has successfully assisted over 90 sponsors in conducting clinical trials across the US, UK, and Europe, achieving results up to three times faster than conventional CROs and often completing trials ahead of schedule.

Company Size

51-200

Company Stage

Series B

Total Funding

$78.7M

Headquarters

London, United Kingdom

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Lindus Health raised $55M to enhance AI technology and expand their commercial team.
  • They launched 'All-In-One' CRO offerings for cardiovascular and infectious disease trials.
  • Partnerships with CDISC and Aktiia enhance data standardization and trial execution.

What critics are saying

  • Increased competition from AI-driven clinical trial companies threatens market position.
  • Relocating headquarters to the US may disrupt established UK and European markets.
  • Expansion into new trial areas may strain Lindus Health's current capabilities.

What makes Lindus Health unique

  • Lindus Health accelerates clinical trials, completing them up to three times faster.
  • They utilize a unique software platform and access to 30 million Electronic Health Records.
  • Their commercial model aligns incentives with fixed-priced quotes and milestone-based payments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Unlimited Paid Time Off

Flexible Work Hours

Mental Health Support

Enhanced Parental Leave

Professional Development Budget

Cycle to work scheme

Stock Options

Regular team events

A new laptop as your main workstation

Growth & Insights and Company News

Headcount

6 month growth

-6%

1 year growth

-6%

2 year growth

6%
Lindus Health
Apr 3rd, 2025
Lindus Health Awarded Funding From ARIA to Build Safe and Reliable AI for Clinical Trial Design

Lindus Health awarded funding from ARIA to build safe and reliable AI for clinical trial design.

Aitech365
Feb 14th, 2025
Lindus Health and CDISC Partner on AI to Standardize Data

CDISC is collaborating with Lindus Health, which is utilizing its proprietary AI technology, to accelerate the generation of Biomedical Concepts across both the CDISC Foundational Standards as well as the Therapeutic Area Standards.

WowTale
Jan 22nd, 2025
Lindus Health raises $55M for AI trials

Lindus Health, a London-based startup, has raised $55 million in a Series B funding round led by Balderton Capital, with participation from Creandum, Firstminute, Seedcamp, and Visionaries Club. The company aims to revolutionize clinical trials using AI and automation, facilitating faster drug market entry. Lindus Health plans to relocate its global headquarters to the US, expand its commercial team, and enhance AI-driven clinical trial data analysis.

Finsmes
Jan 22nd, 2025
Lindus Health Secures $55M Series B

Lindus Health, a NYC-based clinical trial company, raised $55M in Series B funding led by Balderton Capital, with participation from Visionaries Club and existing investors Creandum, Firstminute, and Seedcamp. The funds will enhance their AI technology and eClinical platform, Citrus™, for optimizing study design and data monitoring. Since its 2021 launch, Lindus Health has conducted 42 trials, enrolling over 36,000 patients in North America and Europe.

PR Newswire
Dec 10th, 2024
Lindus Health Releases "All-In-One Cardiovascular Cro" Offering For Clinical Trials Serving Cardiovascular Health

NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched their "all-in-one" contract research organization (CRO), site, and technology offering bespoke to the unique needs of cardiovascular clinical trials.Cardiovascular disease is the leading cause of death in both men and women as well as most racial groups in the US. Clinical trials for these conditions require large, diverse participant populations to capture variability in disease presentation and risk factors, along with extended follow-up to assess long-term outcomes and quality of life improvements. Implementing patient-centric approaches in these studies, like remote-monitoring or decentralized trial designs, is also critical to reduce barriers to participation and observe how these interventions perform in the real world. Lindus Health's latest offering equips sponsors with all the necessary resources to navigate these distinct challenges and more that come with conducting clinical trials in the cardiovascular space.To date, Lindus Health has enrolled over 8,000 patients in cardiovascular studies across the US, UK, and EU. Their "All-in-One Cardiovascular CRO" includes end-to-end CRO and site services, industry knowledge, and eClinical technology necessary for sponsors developing therapies and devices to treat and monitor cardiovascular indications."Patient experience is paramount in cardiovascular studies," said Meri Beckwith, co-founder at Lindus Health

INACTIVE